Hikma Pharmaceuticals sell Barclays PLC
Start price
06.01.26
/
50%
€18.40
Target price
06.01.27
-
Performance (%)
2.37%
Price
05.08.26
€18.49
Summary
This prediction is currently active. With a performance of 2.37%, the SELL prediction by Barclays_PLC for Hikma Pharmaceuticals is trending in the wrong direction Dividends of €0.41 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hikma Pharmaceuticals | -2.118% | -2.118% |
| iShares Core DAX® | 3.153% | 1.504% |
| iShares Nasdaq 100 | 7.431% | -1.584% |
| iShares Nikkei 225® | 8.571% | -4.324% |
| iShares S&P 500 | 4.578% | 1.920% |
Comments by Barclays_PLC for this prediction
In the thread Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat